Curaleaf Holdings, Inc. (CURA.TO)

CAD 1.19

(-11.19%)

EBITDA Summary of Curaleaf Holdings, Inc.

  • Curaleaf Holdings, Inc.'s latest annual EBITDA in 2023 was 238.76 Million USD , up 14.54% from previous year.
  • Curaleaf Holdings, Inc.'s latest quarterly EBITDA in 2024 Q2 was 63.27 Million USD , down -8.22% from previous quarter.
  • Curaleaf Holdings, Inc. reported an annual EBITDA of 300.24 Million USD in 2022, up 24.64% from previous year.
  • Curaleaf Holdings, Inc. reported an annual EBITDA of 278.97 Million USD in 2021, up 347.85% from previous year.
  • Curaleaf Holdings, Inc. reported a quarterly EBITDA of 94.35 Million USD for 2024 Q1, down -1.08% from previous quarter.
  • Curaleaf Holdings, Inc. reported a quarterly EBITDA of 67.98 Million USD for 2023 Q3, up 48.5% from previous quarter.

Annual EBITDA Chart of Curaleaf Holdings, Inc. (2023 - 2016)

Historical Annual EBITDA of Curaleaf Holdings, Inc. (2023 - 2016)

Year EBITDA EBITDA Growth
2023 238.76 Million USD 14.54%
2022 300.24 Million USD 24.64%
2021 278.97 Million USD 347.85%
2020 179.51 Million USD 17.0%
2019 16.17 Million CAD -344.1%
2018 -26.36 Million CAD -192.58%
2017 -9.01 Million CAD -5573.33%
2016 -158.85 Thousand CAD 0.0%

Peer EBITDA Comparison of Curaleaf Holdings, Inc.

Name EBITDA EBITDA Difference
Aurora Cannabis Inc. 20.47 Million CAD -1066.177%
Avicanna Inc. -7.35 Million CAD 3346.064%
Avant Brands Inc. 4.83 Million CAD -4837.2%
Cardiol Therapeutics Inc. -27.87 Million CAD 956.397%
Crescita Therapeutics Inc. 45 Thousand CAD -530484.444%
Knight Therapeutics Inc. 40.89 Million CAD -483.815%
MediPharm Labs Corp. -10.47 Million CAD 2378.708%
OrganiGram Holdings Inc. -207.61 Million CAD 215.0%
Canopy Growth Corporation -312.82 Million CAD 176.324%
Willow Biosciences Inc. -11.06 Million CAD 2258.602%
Auxly Cannabis Group Inc. -10.82 Million CAD 2305.663%